全基因组测序比表型药敏更准确预测结核分枝杆菌一线药物敏感性
该研究对2016/2017年荷兰收到的1136株结核分枝杆菌复合群分离株同时进行MGIT表型药敏和WGS检测,分析9个耐药相关基因及其启动子区域。WGS对四种一线药物的阴性预测值均≥99.3%,多数 discrepant 结果源于低水平耐药,WGS可减少约90%分离株对表型药敏的需求。
要点
- WGS对利福平、异烟肼、乙胺丁醇和吡嗪酰胺的阴性预测值均≥99.3%。
- MGIT与WGS不一致多因低浓度生长或延长培养提示低水平耐药。
- 在低发病率低耐药国家,WGS可减少约90%分离株的表型药敏需求。
核心结论
- 在荷兰这类低结核发病率、低耐药流行国家,WGS可减少约90%分离株对表型药敏的需求,并准确检测常规药敏常漏检的低水平耐药突变。
研究设计与样本
- 对2016/2017年收到的1136株MTBC分离株(其中1121株来自荷兰的常规分离株)同时进行MGIT表型药敏和WGS检测。
- 检测rpoB、katG、fabG1、ahpC、inhA、embA、embB、pncA和rpsA九个基因和/或其启动子区域的耐药相关突变。
- 对MGIT/WGS结果不一致的分离株及结果一致对照组,在临界浓度和更低浓度下用MGIT复测,并延长培养至对照管阳性后45天。
主要发现
- WGS对利福平、异烟肼、乙胺丁醇和吡嗪酰胺四种一线药物的阴性预测值均≥99.3%。
- 异烟肼和乙胺丁醇的大部分不一致由低浓度下生长解释,利福平的不一致由MGIT延长培养解释,均提示低水平耐药。
关键数值与推荐
- WGS对四种一线抗结核药物的阴性预测值均≥99.3%。
- 在荷兰应用WGS可减少约90%分离株对表型药敏的需求。
临床怎么用
- 在低结核发病率和低耐药流行地区,可优先采用WGS预测一线药物敏感性,减少表型药敏检测量。
- 对WGS与表型药敏不一致的结果,应警惕低水平耐药,必要时用低浓度或延长培养的MGIT复测确认。
局限性
- 研究基于荷兰低发病率低耐药流行背景,结论外推至高发病率或高耐药地区需谨慎。
- 仅分析9个基因和/或启动子区域,未覆盖所有潜在耐药机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Drug-susceptibility testing (DST) of Mycobacterium tuberculosis complex (MTBC) isolates by the Mycobacteria Growth Indicator Tube (MGIT) approach is the most widely applied reference standard. However, the use of WGS is increasing in many developed countries to detect resistance and predict susceptibility. We investigated the reliability of WGS in predicting drug susceptibility, and analysed the discrepancies between WGS and MGIT against the first-line drugs rifampicin, isoniazid, ethambutol and pyrazinamide. METHODS: DST by MGIT and WGS was performed on MTBC isolates received in 2016/2017. Nine genes and/or their promotor regions were investigated for resistance-associated mutations: rpoB, katG, fabG1, ahpC, inhA, embA, embB, pncA and rpsA. Isolates that were discrepant in their MGIT/WGS results and a control group with concordant results were retested in the MGIT, at the critical concentration and a lower concentration, and incubated for up to 45 days after the control tube became positive in the MGIT. RESULTS: In total, 1136 isolates were included, of which 1121 were routine MTBC isolates from the Netherlands. The negative predictive value of WGS was ≥99.3% for all four first-line antibiotics. The majority of discrepancies for isoniazid and ethambutol were explained by growth at the lower concentrations, and for rifampicin by prolonged incubation in the MGIT, both indicating low-level resistance. CONCLUSIONS: Applying WGS in a country like the Netherlands, with a low TB incidence and low prevalence of resistance, can reduce the need for phenotypic DST for ∼90% of isolates and accurately detect mutations associated with low-level resistance, often missed in conventional DST.
引用
- Jajou R, van der Laan T, de Zwaan R, et al. WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. J Antimicrob Chemother. 2019. PMID: 31119271. doi:10.1093/jac/dkz215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。